<DOC>
	<DOCNO>NCT02607670</DOCNO>
	<brief_summary>This Phase 2 , randomize , double-blind , placebo-controlled study TAT4 Gel reduction moderate severe nasolabial fold .</brief_summary>
	<brief_title>Phase 2 Study TAT4 Gel Reduction Nasolabial Folds</brief_title>
	<detailed_description />
	<criteria>Moderate severe , bilateral nasolabial fold Must understand provide inform consent Pregnant lactate woman History skin hypersensitivity atopic dermatitis Any illness disease , investigator 's opinion , would make trial participation inadvisable</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>